Estland - estisk - Ravimiamet

qilu pharma spain s.l. - ertapeneem - infusioonilahuse kontsentraadi pulber - 1g 1tk; 1g 10tk

Den Europæiske Union - estisk - EMA (European Medicines Agency)

les laboratoires servier - agomelatine - depressiivne häire, suur - psychoanaleptics, - täiskasvanute suurte depressiivsete episoodide ravi.

Estland - estisk - Ravimiamet

fresenius kabi polska sp. z o.o. - ertapeneem - infusioonilahuse kontsentraadi pulber - 1g 10tk

Estland - estisk - Ravimiamet

fresenius kabi polska sp. z o.o. - zoledroonhape - infusioonilahuse kontsentraat - 4mg 5ml 5ml 1tk; 4mg 5ml 5ml 10tk; 4mg 5ml 5ml 4tk

Den Europæiske Union - estisk - EMA (European Medicines Agency)

eisai gmbh - lenvatinibmesülaat - kartsinoom, neerurakk - antineoplastilised ained - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.

Den Europæiske Union - estisk - EMA (European Medicines Agency)

merck europe b.v.  - follitropin alfa, lutropin alfa - viljatus, naine - suguhormoonid ja genitaalsüsteemi, - pergoveris on näidustatud stimulatsiooni folliikulite areng naistel, kellel on raske luteinising-hormoon (lh) ja folliikuleid stimuleeriva hormooni puudulikkus. kliinilistes uuringutes, need patsiendid olid määratletud on endogeensed seerumi lh tase < 1. 2 rÜ / l.

Den Europæiske Union - estisk - EMA (European Medicines Agency)

pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibacterials süsteemseks kasutamiseks, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.

Den Europæiske Union - estisk - EMA (European Medicines Agency)

merck europe b.v. - follitropiin alfa - anovulation; reproductive techniques, assisted; infertility, female; hypogonadism - suguhormoonid ja genitaalsüsteemi, - anovulation (kaasa arvatud polütsüstiliste munasarjade haigus, pcod) naistel, kellel on olnud allu ravile klomifeen tsitraat. stimulatsiooni multifollicular arengut patsientidel, toimumas superovulation jaoks viljastamise tehnoloogia (art), näiteks in vitro viljastamise (ivf), gamete-sisese fallopian ülekanne (gift) ja zygote-sisese fallopian üleandmine (zift). gonal-f koos luteinising hormooni (lh) preparaat on soovitatav stimulatsiooni folliikulite areng naistel, kellel on raske lh ja fsh puudus. kliinilistes uuringutes on nendel patsientidel olid määratletud on endogeensed seerumi lh tase.

Den Europæiske Union - estisk - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastilised ained - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Den Europæiske Union - estisk - EMA (European Medicines Agency)

gedeon richter plc. - follitropiin alfa - anovulatsioon - suguhormoonid ja genitaalsüsteemi, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. kliinilistes uuringutes on nendel patsientidel olid määratletud on endogeensed seerumi lh tase < 1. 2 rÜ / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.